Luis Sanay | Head, IR |
Jeffrey Dayno | President and CEO |
Jeffrey Dierks | CCO |
Sandip Kapadia | CFO |
Charles Duncan | Cantor Fitzgerald |
Francois Brisebois | Oppenheimer |
David Amsellem | Piper Sandler |
Graig Suvannavejh | Mizuho Securities |
Ami Fadia | Needham |
Corinne Jenkins | Goldman Sachs |
Jason Gerberry | Bank of America |
Danielle Brill | Raymond James |
Good morning everyone. My name is Shelby and I will be your conference operator today. At this time, I would like to welcome everyone to Harmony Biosciences' First Quarter 2023 Financial Results Conference Call. All participant lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.